1. Home
  2. RDW vs SVRA Comparison

RDW vs SVRA Comparison

Compare RDW & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwire Corporation

RDW

Redwire Corporation

HOLD

Current Price

$7.89

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

SVRA

Savara Inc.

HOLD

Current Price

$5.83

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDW
SVRA
Founded
2020
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RDW
SVRA
Price
$7.89
$5.83
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
$12.67
$7.33
AVG Volume (30 Days)
35.4M
1.4M
Earning Date
03-09-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$296,147,000.00
N/A
Revenue This Year
$9.16
N/A
Revenue Next Year
$40.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.87
$1.89
52 Week High
$26.66
$7.01

Technical Indicators

Market Signals
Indicator
RDW
SVRA
Relative Strength Index (RSI) 39.91 53.79
Support Level $8.65 $5.10
Resistance Level $10.40 $5.44
Average True Range (ATR) 1.36 0.33
MACD -0.51 -0.00
Stochastic Oscillator 1.26 78.02

Price Performance

Historical Comparison
RDW
SVRA

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Share on Social Networks: